Alembic Pharmaceuticals fell 2.29% to Rs 694 at 15:08 IST on BSE on profit booking after the stock rose 6.17% in the preceding six trading sessions to Rs 710.30 on 30 December 2015, from a recent low of Rs 669.05 on 21 December 2015.
Meanwhile, the BSE Sensex was up 171.21 points, or 0.66%, to 26,131.24.
On BSE, so far 8,113 shares were traded in the counter, compared with an average volume of 20,196 shares in the past one quarter.
The stock hit a high of Rs 714.30 and a low of Rs 692.10 so far during the day. The stock hit a record high of Rs 791.70 on 15 July 2015. The stock hit a 52-week low of Rs 381.90 on 26 February 2015.
The stock had outperformed the market over the past one month till 30 December 2015, rising 2.67% compared with 0.71% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 3.76% as against Sensex's 0.74% fall.
The large-cap company has an equity capital of Rs 37.70 crore. Face value per share is Rs 2.
On a consolidated basis, Alembic Pharmaceuticals' net profit jumped 274% to Rs 289 crore on 84.5% rise in net sales to Rs 1007.84 crore in Q2 September 2015 over Q2 September 2014.
Alembic Pharmaceuticals is a leading pharmaceutical company.
Powered by Capital Market - Live News